retatrutide type 2 diabetes trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Efficacy and safety of retatrutide,

Lilly has continued to grow rapidly and hit a market cap of over $1 trillion for the first time in 2025

You may also benefit from continuing any IBS-specific treatments (antispasmodics, low-FODMAP diet) alongside your retatrutide protocol

Do not blow on it, do not wipe it, do not rush it

Am J Clin Nutr 8:540546 Nair KS (1987) Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency

Patients on biologic immunosuppressants (infliximab, vedolizumab, ustekinumab) should avoid GLP-1 therapy unless their gastroenterologist explicitly approves, since combining immune-modulating drugs increases infection and flare risk

Most sore throats during Saxenda treatment are coincidental viral or bacterial infections unrelated to the medication